This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Safeguard Scientifics, Inc. (
Q2 2011 Earnings Call
July 27, 2011 9:00 am ET
John Shave – VP, Business Development and Corporate Communications
Peter Boni – President and CEO
Steve Zarrilli – SVP and CFO
Greg Mason – Stifel Nicolaus
Matt Dolan – ROTH Capital Partners
Paul Knight – CLSA
Nick Helen – Sidoti
Good day, ladies and gentlemen. And welcome to the Safeguard Scientifics Second Quarter 2011 Results Conference Call. At this time, all participants are in a listen-only mode. Later, we’ll conduct a question-and-answer session and instructions will be given at that time. (Operator Instructions)
As a reminder, this conference is being recorded. I would now like to turn the conference over to your host Mr. John Shave, Vice President of Business Development and Corporate Communications.
Good morning. Thank you for joining us for Safeguard Scientifics second quarter financial results conference call and update. Joining me on today’s call are Peter Boni, Safeguard’s President and Chief Executive Officer; and Steve Zarrilli, Senior Vice President and Chief Financial Officer.
During today’s call, Peter will review second quarter 2011 highlights and other developments and Steve will discuss Safeguard’s financial results and strategies. After that, we will open up the lines for your questions.
Before we begin, I must remind you that today’s presentation includes forward-looking statements. Reliance on forward-looking statements involve certain risks and uncertainties, including but not limited to the uncertainty of future performance of our partner companies and the risks of acquisition or disposition of interest in partner companies, capital spending by customers and the effect of regulatory and economic conditions generally, as well as the development of the life sciences and technology markets and other uncertainties that are described in our filings.